California Supreme Court declines to hear Wyeth case
Pharma Compliance Alert, February 18, 2009
A California appeals court decision stays since the state’s Supreme Court declined to review an earlier decision that held Wyeth liable for patient injuries originating from a generic version of its acid-reflux medication Reglan.
Read more about the California Supreme Court's decision not to review the case.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Occurrence Reporting:
Take advantage of the information occurrence reports provide and make sustainable enhancements at your facility. Expert...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
-
Creating a Just Culture: A Nurse Leader's Guide
This practical resource explains the process of creating and sustaining a just culture in which staff members are encouraged...
-
Soaring to Success
Co-written by a former airline pilot turned nurse and a risk management expert, this practical resource offers solutions to...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched